Literature DB >> 22332855

A pilot study of low-cost contingency management to increase attendance in an adolescent substance abuse program.

Christopher E Branson1, Anna Maria Barbuti, Philip Clemmey, Lisa Herman, Phintso Bhutia.   

Abstract

Numerous studies demonstrate the efficacy of contingency management (CM) for improving patient outcomes, yet it is rarely used in treatment settings due to the high cost of implementation. This quasi-experimental study (N = 52) examined the effect of a low-cost "Fishbowl" CM intervention on attendance/retention in an early intervention adolescent substance abuse program. The CM group attended significantly more sessions compared to the control group. Furthermore, the CM intervention costs $3.27 per patient per session. Our findings support the use of low-cost CM to improve adolescent attendance in clinical settings.
Copyright © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Year:  2012        PMID: 22332855     DOI: 10.1111/j.1521-0391.2011.00204.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  12 in total

1.  Substance Abuse Treatment Patients in Housing Programs Respond to Contingency Management Interventions.

Authors:  Carla J Rash; Sheila M Alessi; Nancy M Petry
Journal:  J Subst Abuse Treat       Date:  2016-07-19

2.  A randomized trial of contingency management reinforcing attendance at treatment: Do duration and timing of reinforcement matter?

Authors:  Nancy M Petry; Sheila M Alessi; Carla J Rash; Danielle Barry; Kathleen M Carroll
Journal:  J Consult Clin Psychol       Date:  2018-10

3.  Convention Versus Deviance: Moral Agency in Adolescent Gang Members' Decision Making.

Authors:  Julia Dickson-Gomez; Maria Pacella; Michelle Renee Broaddus; Katherine Quinn; Carol Galletly; Justin Rivas
Journal:  Subst Use Misuse       Date:  2016-12-23       Impact factor: 2.164

4.  A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth.

Authors:  Amanda M Palmer; Rachel L Tomko; Lindsay M Squeglia; Kevin M Gray; Matthew J Carpenter; Tracy T Smith; Jennifer Dahne; Benjamin A Toll; Erin A McClure
Journal:  Drug Alcohol Depend       Date:  2022-01-19       Impact factor: 4.492

5.  Client incentives versus contracting and staff incentives: how care continuity interventions in substance abuse treatment can improve residential to outpatient transition.

Authors:  Shauna P Acquavita; Sandra Stershic; Rajni Sharma; Maxine Stitzer
Journal:  J Subst Abuse Treat       Date:  2013-01-30

Review 6.  Advances in Research on Contingency Management for Adolescent Substance Use.

Authors:  Catherine Stanger; Amy Hughes Lansing; Alan J Budney
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2016-10

Review 7.  A review of the literature on contingency management in the treatment of substance use disorders, 2009-2014.

Authors:  Danielle R Davis; Allison N Kurti; Joan M Skelly; Ryan Redner; Thomas J White; Stephen T Higgins
Journal:  Prev Med       Date:  2016-08-08       Impact factor: 4.018

8.  Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study.

Authors:  Maxine Stitzer; Tim Matheson; Colin Cunningham; James L Sorensen; Daniel J Feaster; Lauren Gooden; Alexis S Hammond; Heather Fitzsimons; Lisa R Metsch
Journal:  Addict Sci Clin Pract       Date:  2017-06-27

9.  Financial Incentives for Adherence to Hepatitis C Virus Clinical Care and Treatment: A Randomized Trial of Two Strategies.

Authors:  David A Wohl; Andrew G Allmon; Donna Evon; Christopher Hurt; Sarah Ailleen Reifeis; Harsha Thirumurthy; Becky Straub; Angela Edwards; Katie R Mollan
Journal:  Open Forum Infect Dis       Date:  2017-05-05       Impact factor: 3.835

10.  End User-Informed Mobile Health Intervention Development for Adolescent Cannabis Use Disorder: Qualitative Study.

Authors:  Kara Bagot; Elizabeth Hodgdon; Natasha Sidhu; Kevin Patrick; Mikaela Kelly; Yang Lu; Eraka Bath
Journal:  JMIR Mhealth Uhealth       Date:  2019-10-04       Impact factor: 4.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.